This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Septo-optic Dysplasia
Information about Septo-optic Dysplasia: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Septo-optic Dysplasia
Most recent studies have shown that Septo-optic Dysplasia shares some biological mechanisms with blind-vision, congenital-abnormality, congenital-absence, diabetes-mellitus, dwarfism, dysplasia, growth-disorders, holoprosencephaly, hypoglycemia, hypopituitarism, hypoplasia, nervousness, nystagmus, optic-nerve-hypoplasia, pituitary-diseases, schizencephaly, somatotropin-deficiency.
Among the many pathways, these few ones have gauged particular interests from scientists studying Septo-optic Dysplasia, and have been seen in publications frequently: Anterior Neuropore Closure, Axon Guidance, Bone Maturation, Brain Development, Cell Differentiation, Cell Proliferation, Central Nervous System Development, Cognition, Corpus Callosum Development, Developmental Process, Eye Development, Gland Development, Hormone Secretion, Localization, Myelination, Nervous System Development, Pathogenesis, Pituitary Gland Development, Secretion, System Development
Quite a number of genes have been found to play important roles in Septo-optic Dysplasia, such as AVP, GGH, GH1, GHRH, HES1, HESX1, IGF1, LHX3, LHX4, POMC, POU1F1, PRL, PROP1, SLC20A1, SOD1, SOX2, SOX3, TRH. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.